Skip to content
Search

Latest Stories

Gisela Abbam reappointed as GPhC Chair

Gisela took on the role of GPhC chair in 2022

Gisela Abbam reappointed as GPhC chair

Gisela Abbam

Gisela Abbam has been reappointed as Chair of the General Pharmaceutical Council (GPhC) for a second term.

Previously, Gisela was Chair of the British Science Association (BSA). She took on the role of GPhC chair on 14 March 2022.


The Privy Council confirmed her reappointment, extending her tenure from 1 April 2025 until the end of March 2029.

Commenting on her reappointment, Gisela said: “I am delighted to be reappointed as chair and to continue to lead the important work being carried out at the GPhC.

“I understand that there are significant ongoing challenges for pharmacy and we will continue the listening exercise to provide whatever support we can.”

Gisela acknowledged that patients and their carers have been affected by medicines shortages, while pharmacy teams are grappling with workplace and financial pressures, impacting overall well-being.

She expressed appreciation for those working in pharmacy who are supporting their communities and helping people with their health needs while reaffirming the GPhC’s commitment to use all of its regulatory levers and influence to make a positive difference.

“Major reforms to health and social care are currently being discussed across England, Scotland and Wales.

“I aim to make sure pharmacy and pharmacy regulation is at the heart of those discussions, to ensure patients and the public get safe and effective care and have confidence in pharmacy now and in the future,” she added.

Elizabeth Mailey, a pharmacist member of Council, who was involved in the reappointment process, shared that Gisela has effectively led the Council to help drive forward their aims in her first term and has brought a real focus on “how the GPhC can support pharmacy, and the whole pharmacy team, to deliver improved care for patients and the public.”

“I am delighted that Gisela has been reappointed for a second term, so Gisela can continue to provide clear leadership as the GPhC finalises and implements its strategy for the next five years,” she said.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less